DNA Methylation and Bladder Cancer: Where Genotype does not Predict Phenotype

Author(s): Amit Sharma, Heiko Reutter, Jörg Ellinger*.

Journal Name: Current Genomics

Volume 21 , Issue 1 , 2020

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Nearly three decades ago, the association between Bladder cancer (BC) and DNA methylation has initially been reported. Indeed, in the recent years, the mechanism connecting these two has gained deeper insights. Still, the mediocre performance of DNA methylation markers in the clinics raises the major concern. Strikingly, whether it is the inter-individual methylation variations or the paucity of knowledge about methylation fingerprints lying within histologically distinct subtypes of BC requires critical discussion. In the future, besides identifying the initial causative factors, it will be important to illustrate the cascade of events that determines the fraction of the genome to convey altered methylation patterns specific towards each cancer type.

Keywords: Bladder cancer, DNA methylation, epigenetic, cancer biomarkers, genotype, phenotype.

Rights & PermissionsPrintExport Cite as


Article Details

VOLUME: 21
ISSUE: 1
Year: 2020
Page: [34 - 36]
Pages: 3
DOI: 10.2174/1389202921666200102163422
Price: $65

Article Metrics

PDF: 7